HCPCS Level IIdrugActive
J7204
Inj recombin esperoct per iu
BETOS: O1E
Effective: 2020-07-01
Referenced in 5 policies
Description
Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Esperoct
Manufacturer
Novo Nordisk, Inc
HCPCS Dosage
1 IU
Billing Units
1.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.